China NMPA Inspection - Inner Mongolia Yuhangren Cosmetics Co., Ltd. - December 11, 2024

The National Medical Products Administration (NMPA) recently conducted unannounced inspections of Inner Mongolia Yuhangren Cosmetics Co., Ltd. and Guangxi Jinshengtang Biotechnology Co., Ltd. The inspection results, announced on December 5, 2024, revealed significant non-compliance with regulatory standards. Both companies were found to have violated the "Cosmetics Supervision and Management Regulations" and the "Cosmetics Production Quality Management Standards," exhibiting serious deficiencies in their production quality management systems. To ensure public safety, the NMPA has directed the respective regional drug administrations in Inner Mongolia and Guangxi to initiate investigations, impose legal penalties for suspected illegal activities, and mandate the suspension of production and operations. The companies are also required to promptly rectify all identified issues. This action underscores the NMPA's commitment to upholding stringent quality and safety standards within the cosmetics industry.